Article

H3K27me3 is a determinant of chemotolerance in triple-negative breast cancer

2021-01-04

Abstract excerpt

<h4>Summary</h4> Triple-negative breast cancer is associated with the worst prognosis and the highest risk of recurrence among all breast cancer subtypes 1 . Residual disease, formed by cancer cells persistent to chemotherapy, remains one of the major clinical challenges towards full cure 2,3 . There is now consensus that non-genetic processes contribute to chemoresistance in various tumor types, notably throug...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 05e02a96-37ae-5fe8-8682-db04bf8ab760
DOI: 10.1101/2021.01.04.423386

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

H3K27me3 is a determinant of chemotolerance in triple-negative breast cancerDOI 10.1101/2021.01.04.423386Read

Decoding gene regulatory circuitry underlying TNBC chemoresistance reveals biomarkers for therapy response and therapeutic targetsSemantic proximity Read

A single-nucleus multimodal framework reveals epigenomic priming of chemoresistant states in ovarian cancerSemantic proximity Read

Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancerSemantic proximity Read

Luminal progenitors undergo partial epithelial-to-mesenchymal transition at the onset of basal-like breast tumorigenesisSemantic proximity Read

H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasisSemantic proximity Read

Genetic and epigenetic driven variation in regulatory regions activity contribute to adaptation and evolution under endocrine treatmentSemantic proximity Read

Genetic and epigenetic driven variation in regulatory regions activity contribute to adaptation and evolution under endocrine treatmentSemantic proximity Read

Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted TherapySemantic proximity Read

Drug-tolerant persister cell in cancer: reversibility, microenvironmental interplay, and therapeutic strategiesSemantic proximity Read

Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persistersSemantic proximity Read

Stem-like breast cancer cells in the activated state resist genetic stress via TGFBI-ZEB1Semantic proximity Read

Persister cancer cells are characterized by H4K20me3 heterochromatin that defines a low inflammatory profileSemantic proximity Read